CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Clareon monofocal Intraocular lens (toric and non-toric models)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05526781
NCT05526781N/ACompleted
CompareCT.gov

Visual Outcomes and Patient Satisfaction With Implantation of the Clareon Monofocal IOL With the New Clareon Manual Monarch IV IOL Delivery System

Eye Consultants of Atlanta·observational·Posted Sep 2, 2022·Updated Mar 26, 2025

In Brief

An observational study evaluating Clareon monofocal Intraocular lens (toric and non-toric models) for Cataract. Completed, enrolled 34 participants across 1 site.

Detailed Summary

To evaluate visual outcomes, in-the-bag placement and patient satisfaction in patients implanted with either Clareon monofocal or Clareon monofocal toric IOLs with the Monarch IV inserter and targeted for emmetropia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsSengi

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 2, 2022
Enrollment StartSep 21, 2022
Primary CompletionMar 12, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 3.8 years ago

Interventions

Clareon monofocal Intraocular lens (toric and non-toric models)device

Bilateral implantation of the Clareon monofocal Intraocular lens (toric and non-toric models) with the Monarch IV inserter